NCT05219734Active, not recruiting
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Source: ClinicalTrials.gov · Last updated 12 Mar 2024
Brief summary (registry, in English)
This study recruits patient with solid tumor types for sample collection and monitoring. Participants will provide blood and archival tissue samples in order to create a Personalized Cancer Monitoring (PCM) assay. This assay will be used to detect circulating tumor DNA (ctDNA) levels in the blood over time and hopefully contribute to improvements in residual disease detection methods for future patients. Results from this assay will be provided to participants and providers but providers are not asked to change patient care based on this information.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 20 Dec 2021
- Start date
- 29 Nov 2021
- Primary completion date
- Dec 2026
- Lead sponsor
- Invitae Corporation
- Diseases
- Bladder cancer, Lung cancer, Colorectal cancer
- NCT number
- NCT05219734
What you commit to
- Study type: Observational
- Planned participants: 400
- From 29 Nov 2021 to the primary completion date, Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants diagnosed with CNS cancers, sarcomas or hematologic malignancies such as leukemia or lymphoma .
- Participants with more than one primary cancer
Age
- Participants who are \<18 years of age
- Participants with FFPE slides older than 10 years
Other
- Participants who are deemed medically unstable
- Participants who are deemed to be "difficult to draw" blood from.
- Participants who are pregnant
- Any other reason that, in the Investigator's judgment, that would preclude the participant from being able to participate in the study
- Participants for which a pathology report is not available
Who the study is looking for
- Stated ability to give informed consent by participant.
- Stated health status of participant as healthy enough to provide Biological Material.
- Individuals diagnosed with solid cancer of any type, including but not limited to colorectal, non-small cell lung, breast, ovarian and bladder cancers, regardless of the length of time since diagnosis and regardless of previous therapies.
- Participant is of any biological sex and \>18 years of age
- Participant has not undergone a blood transfusion within the previous three weeks
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbus Regional Health Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
| Onslow Radiation Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.